Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity

© 2013.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 149(2013), 3 vom: 03. Dez., Seite 365-78
1. Verfasser: Zhang, Li (VerfasserIn)
Weitere Verfasser: Bertucci, Anne M, Ramsey-Goldman, Rosalind, Harsha-Strong, Elizabeth Randall, Burt, Richard K, Datta, Syamal K
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2013
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't 1,25(OH)(2)D(3) 1,25-dihydroxyvitamin D3 APG Apigenin Autoimmunity DEX H mehr... HCQ HSCT Human LAP ODN Peptide epitopes RA RAPA Rapamycin SLE Systemic lupus erythematosus T cells TSA Tolerance Trichostatin A dexamethasone hematopoietic stem cell transplantation histone hydroxychloroquine iTreg induced regulatory T cells latency associated peptide oligonucleotide. retinoic acid systemic lupus erythematosus Anti-Inflammatory Agents Antigens, CD Autoantibodies Epitopes FOXP3 protein, human Forkhead Transcription Factors Histones Nucleosomes Peptides Receptors, Transforming Growth Factor beta SMAD2 protein, human SMAD3 protein, human Smad2 Protein Smad3 Protein Transforming Growth Factor beta Protein Serine-Threonine Kinases EC 2.7.11.1 Receptor, Transforming Growth Factor-beta Type I EC 2.7.11.30 TGFBR1 protein, human Tgfbr1 protein, mouse